Universal Biosensors Balance Sheet Health
Financial Health criteria checks 3/6
Universal Biosensors has a total shareholder equity of A$18.7M and total debt of A$607.4K, which brings its debt-to-equity ratio to 3.3%. Its total assets and total liabilities are A$27.9M and A$9.2M respectively.
Key information
3.3%
Debt to equity ratio
AU$607.39k
Debt
Interest coverage ratio | n/a |
Cash | AU$7.04m |
Equity | AU$18.66m |
Total liabilities | AU$9.23m |
Total assets | AU$27.90m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: UBI's short term assets (A$20.1M) exceed its short term liabilities (A$4.9M).
Long Term Liabilities: UBI's short term assets (A$20.1M) exceed its long term liabilities (A$4.4M).
Debt to Equity History and Analysis
Debt Level: UBI has more cash than its total debt.
Reducing Debt: UBI's debt to equity ratio has increased from 0% to 3.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: UBI has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: UBI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 41.4% each year